In line with this, we demonstrate that the S81L mutation abolishes Gnb5-BACE1 interaction (Fig 6), reinforcing its critical role in regulating BACE1 expression and potentially contributing to AD pathophysiology (Fig 7). This evidence concerns the gene GNB5 and Alzheimer disease.